New findings from the INHALE-3 Extension Study (led-by GCDTR members Jaeb Center for Health Research)! Inhaled technosphere insulin (TI) + insulin degludec sustained improved HbA1c levels over 30 weeks in adults with type 1 diabetes. 42% reached A1C
Inhaled technosphere insulin plus degludec improves HbA1c in type 1
More from GCDTR
All news
Dr. Jacob Kariuki receives NIH R01 for PATH activity program
Congratulations to Dr. Jacob Kariuki (Kigo Kariuki), Associate Professor at Nell Hodgson Woodruff School of Nursing at Emory University on receiving an NIH R01 award to advance his research on Physical Activity for The Heart (PATH)!
Congratulations to GCDTR, Director and Emory Global Diabetes Research Center, Director of Data Analytics & Reporting, Dr....
Congratulations to GCDTR, Director and Emory Global Diabetes Research Center, Director of Data Analytics & Reporting, Dr. Jeff Mills, Ed.D, MBA on receiving an National Science Foundation (NSF)-supported ACCESS Discovery Project! ACCESS is a National Science Foundation-supported program that connects…
Roy Beck identifies donor damage and complications increase DMEK cell loss
What factors influence corneal graft health after Descemet membrane endothelial keratoplasty (DMEK)?